Home/Pipeline/LVL Chronic Pain Trial

LVL Chronic Pain Trial

Chronic Pain

Phase 2Active

Key Facts

Indication

Chronic Pain

Phase

Phase 2

Status

Active

Company

Celadon Pharmaceuticals

About Celadon Pharmaceuticals

Celadon Pharmaceuticals is a vertically integrated UK biotech positioned as a leader in developing and manufacturing prescription cannabis-based medicines. The company's core assets include a 100,000 sq ft EU-GMP licensed cultivation and API production facility and a conditionally MHRA-approved Phase 2 clinical trial for chronic pain. Its strategy combines in-house R&D for IP generation with strategic investments, such as in Kingdom Therapeutics for autism spectrum disorder, aiming to build a robust data package for NHS reimbursement and commercial sales.

View full company profile

Therapeutic Areas

Neurology Rare Disease

Other Chronic Pain Drugs

Drug	Company	Phase	Status
SCI-160	SciSparc	Preclinical	Active
Injectrode Platform for Chronic Pain	Neuronoff	Pre-clinical	Active
Novel PNS System	Nervonik	First-in-Human Completed	Active
Pain Pipeline	Centrexion Therapeutics	Clinical Stage	Active
High-Definition Spinal Cord Stimulation	Micro-Leads	Unknown	Active
Precision Medicine for Pain	MindX Sciences	Commercial	Active
Chronic Pain Program	Current Surgical	Research	Active
N-19a	Neurocarrus	Pre-clinical	Active
Nav1.7 ASO	Quiver Bioscience	Discovery	Active
Nav1.8 ASO	Quiver Bioscience	Discovery	Active
Dual Nav1.7/1.8 ASO	Quiver Bioscience	Discovery	Active
TMS for Chronic Pain	Magstim	Commercial/Clinical Development	Active